Keyword: Reckitt Benckiser
News
04.07.2014
- Bayer HealthCare said it plans to keep consumer brands such as Dr. Scholl's and Coppertone it picked up in its $14 billion buy of US Merck's non-prescription drugs business in May...
News
04.06.2014
- The US Environmental Protection Agency (EPA) has reached agreement with consumer chemicals producer Reckitt Benckiser to cancel 12 d-CON mouse and rat poison products that no...
News
07.05.2014
- As expected, Germany's Bayer has emerged as the winner of the race to acquire U.S. Merck's consumer care business. The $14.2 billion deal announced on May 5 is expected to close in...
News
05.05.2014
- With UK consumer health giant Reckitt having bowed out of the race to acquire the consumer business of U.S. drugmaker Merck & Co, Germany's Bayer is said to be in exclusive...
News
21.02.2014
- A handful of consumer and healthcare companies including Germany's Bayer and Switzerland's Novartis are exploring a deal for Merck & Co's consumer healthcare business, people...
News
13.02.2014
- Reckitt Benckiser has said the strategic review of its pharmaceuticals business is still in progress and it will update investors over the course of 2014. In October 2013, the...
News
13.02.2013
- An unusually severe cold and flu season in the United States helped drive full-year profits higher at Britain's Reckitt Benckiser, maker of Strepsils throat lozenges and Mucinex...
News
27.11.2012
- Merck KGaA said it would keep its non-prescription drugs unit even as a tussle over vitamin maker Schiff Nutrition highlighted the rich sale premium it could fetch. Merck's...
